Published in Circ J on December 18, 2009
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J (2012) 1.16
Iron status in patients with chronic heart failure. Eur Heart J (2012) 0.99
The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Heart Fail Rev (2011) 0.93
Hepcidin in anemia of chronic heart failure. Am J Hematol (2011) 0.80
Iron deficiency anemia in heart failure. Heart Fail Rev (2013) 0.78
Cardiac Hepcidin Expression Associates with Injury Independent of Iron. Am J Nephrol (2016) 0.75
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
Safety and efficacy of endovascular therapy with a simple homemade carbon dioxide delivery system in patients with ileofemoral artery diseases. Circ J (2012) 2.38
Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol (2003) 2.13
Inhibition of mTORC2 but not mTORC1 up-regulates E-cadherin expression and inhibits cell motility by blocking HIF-2α expression in human renal cell carcinoma. J Urol (2012) 2.08
Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol (2006) 2.05
Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv (2014) 1.99
Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc (2010) 1.95
Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol (2003) 1.95
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol (2008) 1.85
Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol (2003) 1.80
Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol (2009) 1.68
Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats. Hypertension (2011) 1.66
Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol (2002) 1.63
Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Gastrointest Endosc (2013) 1.58
Endoscopic papillary balloon dilation for the management of bile duct stones in patients 85 years of age and older. Gastrointest Endosc (2008) 1.56
Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart. Sci Transl Med (2013) 1.55
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Deficiency of nectin-2 leads to cardiac fibrosis and dysfunction under chronic pressure overload. Hypertension (2009) 1.50
Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart (2010) 1.48
Impact of introduction of wire-guided cannulation in therapeutic biliary endoscopic retrograde cholangiopancreatography. J Gastroenterol Hepatol (2011) 1.47
Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism. Circ J (2014) 1.46
Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol (2004) 1.44
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut (2007) 1.43
Covered biliary metal stent: which are worse--the concepts, current models, or insertion methods? Gastrointest Endosc (2011) 1.42
Comparing the vascular response in implantation of self-expanding, bare metal nitinol stents or paclitaxel-eluting nitinol stents in superficial femoral artery lesions: a serial optical frequency domain imaging study. EuroIntervention (2016) 1.39
Risk Factors for Progression of Degenerative Aortic Valve Disease in the Japanese- The Japanese Aortic Stenosis Study (JASS) Prospective Analysis. Circ J (2015) 1.39
Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol (2004) 1.37
Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc (2005) 1.32
Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol (2006) 1.31
Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Circulation (2004) 1.24
Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc (2009) 1.22
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol (2009) 1.20
Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc (2002) 1.20
Bilateral epididymal sarcoidosis presenting without radiographic evidence of intrathoracic lesion: Review of sarcoidosis involving the male reproductive tract. Int J Urol (2004) 1.19
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production. Rheumatol Int (2009) 1.13
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation (2009) 1.12
Management of distal malignant biliary obstruction with the ComVi stent, a new covered metallic stent. Surg Endosc (2009) 1.11
Discordant repolarization alternans-induced atrial fibrillation is suppressed by verapamil. Circ J (2005) 1.09
Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease. J Hypertens (2012) 1.09
Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol (2006) 1.08
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine. Invest New Drugs (2010) 1.08
Impact of S-1 on the survival of patients with advanced pancreatic cancer. Pancreas (2010) 1.06
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res (2002) 1.06
Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer (2008) 1.06
Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol (2006) 1.05
Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta (2006) 1.05
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica (2007) 1.04
Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol (2004) 1.03
Japanese multicenter estimation of WallFlex duodenal stent for unresectable malignant gastric outlet obstruction. Dig Endosc (2012) 1.01
Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension (2002) 1.01
Transmural biliary drainage can be an alternative to transpapillary drainage in patients with an indwelling duodenal stent. Dig Dis Sci (2014) 1.01
New method of covered wallstents for distal malignant biliary obstruction to reduce early stent-related complications based on characteristics. Dig Endosc (2010) 1.00
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. J Gastroenterol (2011) 1.00
Clinical significance of bile cytology via an endoscopic nasobiliary drainage tube for pathological diagnosis of malignant biliary strictures. J Hepatobiliary Pancreat Sci (2011) 0.99
S-1 monotherapy in patients with advanced biliary tract cancer. Oncology (2009) 0.98
AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension (2004) 0.98
Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes. Am J Physiol Heart Circ Physiol (2008) 0.98
Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica (2008) 0.98
Noninvasive assessment of wall distensibility with the evaluation of diastolic epicardial movement. J Card Fail (2009) 0.98
Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer. Invest New Drugs (2010) 0.97
Newly designed large cell Niti-S stent for malignant hilar biliary obstruction: a pilot study. Surg Endosc (2010) 0.97
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. Arthritis Res Ther (2013) 0.95
OCT assessment of thin-cap fibroatheroma distribution in native coronary arteries. JACC Cardiovasc Imaging (2010) 0.95
A large volume of visceral adipose tissue leads to severe acute pancreatitis. J Gastroenterol (2011) 0.94
Preserved function of the Oddi sphincter after endoscopic papillary balloon dilation. Hepatogastroenterology (2003) 0.94
Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan. Jpn J Clin Oncol (2010) 0.94
Procedural implications of intravascular ultrasound morphologic features of chronic total coronary occlusions. Am J Cardiol (2006) 0.94
Short- and long-term outcomes of endoscopic papillary large balloon dilation with or without sphincterotomy for removal of large bile duct stones. Scand J Gastroenterol (2013) 0.94
Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model. J Hypertens (2013) 0.93
Management of malignant gastric outlet obstruction with a modified triple-layer covered metal stent. Gastrointest Endosc (2012) 0.93